• About us
  • Investment profile
  • Investment partners
  • Investment approach
  • Portfolio
  • News and views
  • Contacts
Mackintosh Capital invests in and supports small and medium enterprises (SMEs) as a catalyst for realising their potential
← Capito Systems chosen as one to watch by Virgin Media Business
Oncimmune acquires dedicated commercial testing facility for EarlyCDT-Lung from Health Diagnostic Laboratory, Inc →

Oncimmune’s EarlyCDT-Lung Blood Test detects 8 out of 10 with lung cancer

Posted on September 4, 2015 by admin

For the full article by The Time, visit: http://www.thetimes.co.uk/tto/health/news/article4546858.ece


Mackintosh Capital LLP, Mackintosh House, 136 Newport Road, Cardiff, CF24 1DJ | Tel: +44 (0)2921 25 1455
Copyright 2010 Mackintosh Capital LLP
All rights reserved

Terms of Use and Privacy Policy